K O S PHARMACEUTICALS INC
KOSP
KOSP was delisted on the 14th of December, 2006.
1 hedge funds and large institutions have $3.09M invested in K O S PHARMACEUTICALS INC in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
10% less capital invested
Capital invested by funds: $3.43M → $3.09M (-$334K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RFG
RFP Financial Group
Atlanta,
Georgia
|
-$40.9K |
| 2 |
SHFA
SS&H Financial Advisors
Troy,
Michigan
|
-$30.4K |
KOSP Hedge Fund Activity: Q1 2023 in Review
1 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in K O S PHARMACEUTICALS INC (KOSP) for Q1 2023, worth a combined $3.09M — down 9.8% from $3.43M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of KOSP and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was RFP Financial Group, exiting entirely with an estimated $40.9K sold.
- 1 institutional investor held K O S PHARMACEUTICALS INC (KOSP) as of Q1 2023, down from 2 in Q4 2022.
- Funds reported $3.09M of K O S PHARMACEUTICALS INC stock for Q1 2023, down 9.8% quarter-over-quarter.
- 0 funds opened new K O S PHARMACEUTICALS INC positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest K O S PHARMACEUTICALS INC seller in Q1 2023 was RFP Financial Group, an estimated $40.9K sold.
Based on aggregated 13F filings for Q1 2023.